Response to Alongi et al.

We thank Dr. Alongi and colleagues for their interest in and comments on our article on acute rectal toxicity following EBRT for prostate cancer with either weekly portal imaging or daily CBCT (The RIC-study) [1].

https://ift.tt/2HHlgEI